MEDBOX | category Clinical Guidelines

Clinical Guidelines

Advanced search

Create your MEDBOX

Clinical Guidelines

Advanced search

Create your MEDBOX

Sub-Categories

Communicable Diseases

Gynaecology & Obstetrics

Surgery & Anaesthesia

Radiology and Diagnostic

Neurology & Psychology

Dental & Eye Care

Palliative Care

OUR RECOMMENDATIONS

WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support (2022)

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief (2022)

A Pocket Guide for Clinical Management of Obstetric and Neonatal Emergencies in Africa (2022)

Standard operating procedures for supply chain management of health products for neglected tropical diseases amenable to preventive chemotherapy (2022)

Preparation and administration of REGN-EB3 for Ebola virus disease (‎EVD)‎ (2022)

NEW

NEW

WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support (2022)

Monkeypox (2022)

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief (2022)

Communication Strategy 2021 update (EYE- elimination yellow fever) (2022)

A Pocket Guide for Clinical Management of Obstetric and Neonatal Emergencies in Africa (2022)

LIST OPTIONS

FILTER BY LANGUAGE

FILTER BY COUNTRY

SORT BY

RESULTS/PAGE

LIST TYPE

1317 records

	Preparation and administration of REGN-EB3 for Ebola virus disease (‎EVD)‎ World Health Organization WHO (2022) C_WHO View PDF(1) Download (1) Add to my MEDBOX Guidance for health care workers. Tags: Ebola, Treatment, drugs, infographic, Source: https://apps.who.int/iris/bitstream/hand
	Neutralizing monoclonal antibody mAb114 for Ebola virus disease (‎EVD)‎ World Health Organization WHO (2022) C_WHO View PDF(1) Download (2) Add to my MEDBOX Guidance for health care workers. Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness Tags: Ebola, Treatment, drugs, infographic, Source: https://apps.who.int/iris/bitstream/hand
	Neutralizing monoclonal antibody cocktail REGN-EB3 for Ebola virus disease (EVD) World Health Organization WHO (2022) C_WHO View PDF(1) Download (1) Add to my MEDBOX Guidance for health care workers. Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness Tags: Ebola, Treatment, drugs, infographic, Source: https://apps.who.int/iris/bitstream/hand
	Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations World Health Organization WHO (2022) C_WHO View PDF(0) Download (1) Add to my MEDBOX The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for 5 key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and other closed settings). They present and discuss new recommendations and consolidate a range of recommendations and guidance from current WHO guidelines Tags: sti, viral hepatitis, Guidelines, hiv, opportunistic infections, key populations, Treatment, Source: https://apps.who.int/iris/rest/bitstream
	Malaria chemoprevention efficacy study protocol World Health Organization WHO (2022) C_WHO View PDF(1) Download (1) Add to my MEDBOX Chemoprevention is the use of medicines, either alone or in combination, to prevent malaria infection and its consequences. This publication provides standardized approaches for monitoring and evaluating the efficacy of medicines used for intermittent preventive treatment of malaria in pregnancy, perennial malaria chemoprevention (formerly known as intermittent preventive treatment of malaria in infants), seasonal malaria chemoprevention and intermittent preventive treatment of malaria in school-aged children. It follows the recent release of new and updated WHO recommendations on these interventions Tags: Malaria, chemoprophylaxis, effeciency, medicines, intermittent preventive treatment of malaria, Source: https://apps.who.int/iris/rest/bitstream
	Prise en charge clinique, prévention et maîtrise de l'orthopoxvirose simienne (‎variole du singe)‎ : orientations provisoires pour une intervention rapide, 10 juin 2022 World Health Organization WHO (2022) C_WHO View PDF(1) Download (1) Add to my MEDBOX Interim rapid response guidance, 10 June 2022. It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons. The guidance also addresses considerations for clinical management such as the use of therapeutics, nutritional support, mental health services, and post-infection follow-up. The document provides guidance for clinicians, health facility managers, health workers and infection prevention and control practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, infectious diseases clinics, genitourinary clinics, dermatology clinics, maternity services, paediatrics, obstetrics and gynaecology and acute care facilities that provide care for patients with suspected or confirmed monkeypo Tags: monkeypox, clinical management, guide, prise en charge, orthopoxvirose, variole du singe, Source: https://apps.who.int/iris/bitstream/hand
	Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV World Health Organization (WHO) (2022) C_WHO View PDF(748) Download (320) Add to my MEDBOX Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa. These guidelines update the recommendations that were first released in 2018 on diagnosing, preventing, and managing cryptococcal disease. In response to important new evidence that became available in 2021, these new guidelines strongly recommend a single high dose of liposomal amphotericin B as part of the preferred induction regimen for the treatment of cryptococcal meningitis in people living with HIV. This simplified regimen - a single high dose of liposomal amphotericin B paired with other standard medicines (flucytosine and fluconazole) - is as effective as the previous WHO standard of care, with the benefits of lower toxicity and fewer monitoring demands. The objective of these guidelines is to provide updated, evidence-informed recommendations for treating adults, adolescents and children living with HIV who have cryptococcal disease. These guidelines are aimed at HIV programme managers, policymakers, national treatment advisory boards, implementing partners and health-care professionals providing care for people living with HIV in resource-limited settings with a high burden of cryptococcal disease Tags: HIV, hiv care, hiv treatment, clinical practice guidelines, opportunistic infections, cryptococcal meningitis, Source: https://apps.who.int/iris/rest/bitstream
	Vector control and the elimination of gambiense human African trypanosomiasis World Health Organization WHO (2022) C_WHO View PDF(8) Download (6) Add to my MEDBOX The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT and the monitoring thereof. Seven endemic countries provided reports on recent and ongoing vector control interventions at the national level (Angola, Cameroon, Côte d’Ivoire, Chad, Democratic Republic of the Congo, Guinea and Uganda). Country reports focused on the in situations implementing and supporting vector control activities, the tools and the approaches in use, the coverage of the activities in space and time and their impacts on tsetse populations. Future perspectives for vector control in the respective countries were also discussed, including opportunities and challenges to sustainability Tags: Elimination, HAT, African Trypanosomiasis, Vector Control, interventions, control, tsetse fly, NTD, Neglected Tropical Diseases (NTDs), Source: https://apps.who.int/iris/rest/bitstream
	Laboratory Guidelines for the Detection and Diagnosis of Monkeypox Virus Infection Pan American Health Organisation PAHO (2022) C_WHO View PDF(2) Download (3) Add to my MEDBOX 15 May 2022 Tags: monkeypox, detection, laboratory, Source: https://www.paho.org/en/file/109251/down
	Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection World Health Organization WHO (2022) CC View PDF(10) Download (6) Add to my MEDBOX Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and task-sharing, in addition to the use of point-of-care (POC) HCV viral load assays and reflex viral load testing Tags: hepatiis, Chronic Disease, diagnostic, Point-of-Care-Testing, Source: https://apps.who.int/iris/rest/bitstream

1317 records

1317 records